1. Nissenblatt MJ (1981) The CUP syndrome (carcinoma unknown primary). Cancer Treat Rev 8: 211–224
2. Abbruzzese JL, Raber MN, Frost P (1988) An effective strategy for the evaluation of unknown primary tumors. Cancer Bull 41: 157–161
3. Greco FA, Briasoulis E (2005) Cancer of unknown primary site. In: DeVita VT Jr, Hellmann S, Rosenberg SA (eds) Cancer-principles and practice of ocology. 7th edn. Lippincott Williams and Wilkins, Philadephia, 46: pp 2213–2236
4. Briasoulis E, Tsokos M, Fountzilas G et al. (1998) Bcl2 and p53 protein expression in metastatic carcinoma of unknown primary origin: biological and clinical implications. A Hellenic Cooperative Oncology Group Study. Anticancer Res 18: 1907–1914
5. Pavlidis N, Briasoulis E, Bai M et al. (1995) Overexpression of C-myc, Ras and C-erb-2 oncoproteins in carcinoma of unknown primary origin. Anticancer Res 15: 2563–2567